ODDB.org: Open Drug Database

Zirabev 400 mg/16 ml, Konzentrat zur Herstellung einer Infusionslösung -

Swissmedic Key	67501002	Registration Holder	Pfizer AG
Name	Zirabev 400 mg/16 ml, Konzentrat zur Herstellung einer Infusionslösung	Date of registration	10.05.2020
		Introduction of Sequence	10.05.2020
ATC-Classification	(L01FG01)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	07.16.10.	Show package size
Index Therapeuticus (Swissmedic)	07.16.10.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	962.84	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	1063.55
Feedback	FB
GTIN	7680675010028	Medication Code	Biotechnologika
Pharmacode	7773043	Disponibility

Composition

bevacizumabum 400 mg, acidum succinicum, saccharum, dinatrii edetas, polysorbatum 80, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 16 ml corresp. natrium 9.29 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Bevacizumab	400mg / 16ml

BAG: Active Agent	Dose
Bevacizumab	400 mg

Inactive agents
Succinic Acid
Dinatrii Edetas
Sodium Hydroxide
Polysorbatum 80
Saccharum

Source

Data was imported : 07.08.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH